Spatial distribution of malignant tissue in gliomas: Correlations of 11C-L-methionine positron emission tomography and perfusion-and diffusion-weighted magnetic resonance imaging

Acta Radiologica

Volumn 56, Issue 9, 2015, Pages 1135-1144

  Tietze, Anna ^a   Boldsen, Jens K ^a   Mouridsen, Kim ^a   Ribe, Lars ^a   Dyve, Suzan ^a   Cortnum, Søren ^b   Østergaard, Leif ^a   Borghammer, Per ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Brain brain stem; CNS; Comparative study; Perfusion and diffusion weighted magnetic resonance imaging; PET; Primary neoplasms

Indexed keywords

AMINO ACIDS; BLOOD; BLOOD VESSELS; DIAGNOSIS; DIFFUSION; HEMODYNAMICS; MAGNETIC RESONANCE IMAGING; MAGNETISM; POLYETHYLENE TEREPHTHALATES; POSITRONS; RESONANCE; SURFACE DIFFUSION; TUMORS;

APPARENT DIFFUSION COEFFICIENT MAPS; CEREBRAL BLOOD VOLUME(CBV); CNS; COMPARATIVE STUDIES; DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY (PET); PRIMARY NEOPLASMS; VOLUME OF INTEREST ANALYSIS;

POSITRON EMISSION TOMOGRAPHY;

METHIONINE; RADIOPHARMACEUTICAL AGENT;

ADULT; ANALOGS AND DERIVATIVES; BRAIN TUMOR; COMPARATIVE STUDY; DIAGNOSTIC USE; DIFFUSION WEIGHTED IMAGING; FEMALE; GLIOMA; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; TUMOR INVASION;

ADULT; BRAIN NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; NEOPLASM INVASIVENESS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84944878766     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1177/0284185114550020     Document Type: Article

References (31)

1. Jenkinson MD, Du Plessis DG, Walker C, et al. Advanced MRI in the management of adult gliomas. Br J Neurosurg 2007;21: 550-561.
2. Chen W. Clinical applications of PET in brain tumors. J Nucl Med 2007;48: 1468-1481.
3. Herholz K, Holzer T, Bauer B, et al. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998;50: 1316-1322.
4. Pirotte B, Goldman S, Dewitte O, et al. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: A report of 103 consecutive procedures. J Neurosurg 2006;104: 238-253.
5. Kracht LW, Miletic H, Busch S, et al. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: Local comparison with stereotactic histopathology. Clin Cancer Res 2004;10: 7163-7167.
6. Pirotte BJ, Lubansu A, Massager N, et al. Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors. J Neurosurg 2007;107: 392-399.
7. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology 1994;191: 41-51.
8. Chang SM, Nelson S, Vandenberg S, et al. Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma. J Neurooncol 2009;92: 401-415.
9. Emblem KE, Nedregaard B, Nome T, et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008;247: 808-817.
10. Bisdas S, Kirkpatrick M, Giglio P, et al. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: Ready for prime time in predicting short-term outcome and recurrent disease? Am J Neuroradiol 2009;30: 681-688.
11. Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 2004;9: 528-537.
12. Hilario A, Ramos A, Perez-Nunez A, et al. The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas. Am J Neuroradiol 2011;33: 701-707.
13. Yamasaki F, Kurisu K, Satoh K, et al. Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005;235: 985-991.
14. Paulson ES, Schmainda KM. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: Recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008;249: 601-613.
15. Ostergaard L, Sorensen AG, Kwong KK, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 1996;36: 726-736.
16. Mouridsen K, Friston K, Hjort N, et al. Bayesian estimation of cerebral perfusion using a physiological model of microvasculature. Neuroimage 2006;33: 570-579.
17. Mouridsen K, Hansen MB, Ostergaard L, et al. Reliable estimation of capillary transit time distributions using DSC-MRI. J Cereb Blood Flow Metab 2014. DOI: 10.1038/jcbfm.2014.111.
18. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: Interobserver and intraobserver reproducibility study. Radiology 2002;224: 797-803.
19. Pauleit D, Floeth F, Hamacher K, et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 2005;128: 678-687.
20. Dice LR. Measures of the amount of ecologic association between species. Ecology 1945;26: 297-302.
21. Tibshirani R. Regression Shrinkage and Selection via the Lasso. J R Statist Soc B 1996;58: 267-288.
22. Rachinger W, Goetz C, Popperl G, et al. Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 2005;57: 505-511.
23. Miyagawa T, Oku T, Uehara H, et al. "Facilitated" amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab 1998;18: 500-509.
24. Hu LS, Eschbacher JM, Dueck AC, et al. Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. Am J Neuroradiol 2011;33: 69-76.
25. Floeth FW, Pauleit D, Sabel M, et al. Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in lowgrade glioma. J Nucl Med 2007;48: 519-527.
26. Sadeghi N, Salmon I, Bich NTT, et al. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: Preliminary results. J Magn Reson Imaging 2006;24: 989-994.
27. Berntsson SG, Falk A, Savitcheva I, et al. Perfusion and diffusion MRI combined with (1)(1)C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas. J Neurooncol 2013;114: 241-249.
28. Rose S, Fay M, Thomas P, et al. Correlation of MRIderived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-Fluoro-L-Dopa PET: What are we really measuring with minimum ADC? Am J Neuroradiol 2013;34: 758-764.
29. Van Cauter S, Veraart J, Sijbers J, et al. Gliomas: Diffusion kurtosis MR imaging in grading. Radiology 2012; 263: 492-501.
30. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spinecho MR susceptibility mapping compared with conventional contrast-enhanced MR: Confounding effect of elevated rCBV of oligodendrogliomas. Am J Neuroradiol 2004;25: 214-221.
31. Pirotte B, Goldman S, Salzberg S, et al. Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children: Experience in 9 cases. Pediatric neurosurgery 2003;38: 146-155.